Sylvia Miles, an Indianapolis resident, was diagnosed with lupus in 2006 and later moved to advanced kidney disease. This chronic autoimmune disorder significantly impairs her kidneys, putting her in desperate need of a transplant. Approximately 37 million Americans live with chronic kidney disease (CKD), becoming one of the leading causes of death in the country. CKD and advanced kidney disease cost Medicare billions of dollars in recent years.

Sylvia, like many others, faced a lengthy waitlist and high uncertainties. The average wait time for a kidney transplant is five years, often spent on dialysis. Despite this crisis, about 9,000 kidneys from deceased donors were discarded last year due to perceived viability issues. A new Indiana-based organization, 34 Lives, has emerged to combat this problem, aiming to rehabilitate and revitalize these discarded organs.

Thirty-four people are removed from the transplant waitlist daily due to either advancing disease or death. This calls for desperate measures to save viable kidneys for those in need.

How Kidney Donations Work

Kidney donations come from living and deceased donors. Living donor kidneys are typically healthier and last longer, making them the best option for patients with kidney disease. However, most patients receive a kidney from a deceased donor through a waitlist system.

When a deceased donor kidney is harvested, it is removed, put on ice in a coolbox, and transported to a hospital. The critical moment starts from this process. The organ remains viable for only 24 to 36 hours, after which it significantly deteriorates. The transplant process needs urgent attention, lessening the chances of finding an excellent match with fewer biopsies, medical history, and informative scans.

Dr. Leonardo Riella, a transplant nephrologist at Massachusetts General Hospital, explaining the potential situational paradox, said, “These biopsies are processed very quickly, meaning we cannot do all the stains to look at all the different aspects of the kidney. We may not be able to actually say what’s going on with the rest of the kidney because sometimes things can be spotty in terms of how they affect the kidney.”

Given the short timeframe and limited information, surgeons are cautious about accepting potentially unhealthy kidneys. Dr. Riella explained, “Hospitals don’t have the funds or resources to repair damaged organs. And FDA has yet to approve a process for repairing kidneys, which means a hospital would have to conduct a research study.”

Working to Limit Organ Waste

`

34 Lives4 Ltd, or Thirty-Four Lives, a public benefit company named to signify how the renamed fund aims for a noble cause—iled an observational study which used cutting-edge technology to treat kidneys rejected before they could be transplanted to save Medicare $160 million in several months. Pushing for a longer survival period of kidneys, longer than a day, normally expected to stay outside of the human body, the project continues to ask for advancement beyond previous scientific research on organ preservation—ultimately saving hundreds of lives by treating hyperacute rejection after its successful trials.

“Every kidney transplanted into a patient saves Medicare about $2.5 million.” “We put [the kidney] on a little life support machine that allows us to warm it back up to body temperature,” said Chris Jaynes, co-CEO of 34 Lives and this running study teams’ programs are pushing to rejuvenate kidneys through controlled biologic environment and specialized drainage systems to preserve the organ’s ill-fated life, currently when kidneys are discarded. We run 35 tests, including performing biopsies to check electrolyte production and urine creation. So, ultimately extending the organ stay outside the body with marked medical advancements is bringing about a certain ray of relief and hope for chronic kidney patients.

The life support machine extends the preservation time to three hours more and allows nearly three dozen tests on the kidney to determine electrolytes and gluccore function, for example. Hospitals don’t currently have sufficient resources to repair and support organ functions after they are rejected.

Medicare has covered dialysis and kidney transplantation since 1973, accounting for one-third of its outpatient budget due to kidney disease. Since 1973 Medicare has covered the cost of dialysis and kidney transplantation for patients with renal diseases, regardless of someone’s age, causing 34 Lives’ impact beyond the individual patient. The company has achieved 83 transplants across hospitals and has seen strides.

Although the research is still ongoing, it holds promising potential to alleviate the kidney shortage and provide more opportunities for those waiting for transplantation. Dr. Renee Wegrzyn, director of ARPA-H, said, Imagine a future where we didn’t have to do dialysis at all because we had enough kidneys for everybody. We can turn around somebody in crisis who needs a kidney [within] days to weeks, then release that money into the economy.

One patient transformation is Sylvia Miles of Indianapolis. Miles said, I tell you, I feel amazing. I haven’t had a flare up since I had the transplant, which is a great deal for me.

Indianapolis residents are often the first places to see initial a clinical trials in way to alleviate waiting times and prove a promising strategic point for kidney Evaluating trials.